Market revenue in 2023 | USD 1,503.1 million |
Market revenue in 2030 | USD 4,372.8 million |
Growth rate | 16.5% (CAGR from 2023 to 2030) |
Largest segment | Functional genomics |
Fastest growing segment | Pathway Analysis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery |
Key market players worldwide | Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Eppendorf, Eurofins Scientific SE, Roche Holding AG ADR, GE Aerospace, Illumina Inc, Myriad Genetics Inc, Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc, Qiagen NV, Quest Diagnostics Inc, Thermo Fisher Scientific Inc, 23andMe Holding Co Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genomics market will help companies and investors design strategic landscapes.
Functional genomics was the largest segment with a revenue share of 31.99% in 2023. Horizon Databook has segmented the France genomics market based on functional genomics, epigenomics, pathway analysis, biomarker discovery covering the revenue growth of each sub-segment from 2018 to 2030.
The healthcare system in France relies heavily on government funds and national healthcare insurance. In 2015, a French Plan for Genomic Medicine 2025 was licensed. This plan was further developed and streamlined in 2016 by the French National Alliance for Life Sciences and Health, namely, Aviesan.
It was designed to facilitate the integration of genomic medicine in healthcare. The plan also aimed at establishing a genomic-medicine industry in the nation, boosting economic growth and innovation.
Moreover, the strong presence of well-established & emerging NGS product manufacturers and continuous organic & inorganic growth strategies adopted by them are expected to support the market.
Horizon Databook provides a detailed overview of country-level data and insights on the France genomics market , including forecasts for subscribers. This country databook contains high-level insights into France genomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account